Skip to main content

Table 4 Uni/Multivariate analysis of predictors for iCCA subpe

From: Preoperative subcategorization based on magnetic resonance imaging in intrahepatic cholangiocarcinoma

Imaging features

Univariate analysis for subtype

Multivariate analysis for subtype

p value

OR

95% CI

p value

OR

95%CI

Intratumoral hemorrhage

0.448

2.179

0.292-16.266

   

Restricted diffusion

NA

NA

NA

   

Targetoid restriction

0.002*

0.159

0.050-0.508

0.008*

0.079

0.012-0.520

Arterial phase hypoenhancement

0.003*

8.571

2.118-34.688

0.028*

8.186

1.257-53.287

Rim APHE

0.058

0.813

0.162-1.032

   

Non-rim APHE

0.497

0.654

0.192-2.228

   

Targetoid appearance in T2

0.006*

0.116

0.025-0.532

0.083

0.141

0.015-1.294

Peripheral washout

0.087

0.356

0.109-1.162

   

Non-peripheral washout

0.413

0.400

0.045-3.584

   

Delayed enhancement

0.901

1.083

0.305-3.847

   

Corona enhancement

0.223

0.553

0.197-1.434

   

Enhancing capsule

0.707

0.764

0.188-3.112

   

Tumor in vein

0.026*

4.489

1.200-16.798

0.606

0.582

0.074-4.567

Intrahepatic duct dilatation

< 0.001*

15.532

5.8343-45.156

< 0.001*

37.500

6.985-201.329

Hepatic capsule retraction

0.395

0.679

0.278-1.657

   
  1. *p < 0.05. iCCA Intrahepatic cholangiocarcinoma, OR Odds Ratio, 95% CI 95% Confidence interval, APHE Arterial phase hyperenhancement, LR LI-RADS